BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2026 8:38:32 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-01-13 06:15 |
|
Peer-Review Started |
|
2026-01-13 06:16 |
|
First Decision by Editorial Office Director |
|
2026-01-16 06:58 |
|
Return for Revision |
|
2026-01-16 06:58 |
|
Revised |
|
2026-01-30 11:06 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-02 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-02 08:08 |
|
Articles in Press |
|
2026-03-02 08:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-29 13:59 |
|
Publish the Manuscript Online |
|
2026-06-15 08:38 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Control Study |
| Article Title |
Is the metabolic dysfunction-associated steatotic liver disease a predictor of chronic kidney disease?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nashwa M Azoz, Marwa A Shehata, Wael A Abbas, Rabea A Gadelkareem and Essam M Abdel Aziz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rabea A Gadelkareem, Assistant Professor, Department of Urology, Assiut Urology and Nephrology Hospital, Faculty of Medicine, Assiut University, Elgamaa Street, Assiut 71515, Egypt. rabeagad@aun.edu.eg |
| Key Words |
Chronic kidney disease; Diabetes mellitus; Hepatic fibrosis; Kidney injury; Metabolic dysfunction-associated steatotic liver disease; Obesity |
| Core Tip |
Metabolic dysfunction-associated steatotic liver disease (MASLD) is now recognized as a multisystem disease. It is closely linked to obesity, insulin resistance, type-2 diabetes mellitus (DM), dyslipidemia, and hypertension. The present case-control study revealed that MASLD is strongly associated with chronic kidney disease, particularly in patients with DM and advanced hepatic fibrosis. The factors associated with chronic kidney disease included hepatic fibrosis score, steatosis score, Homeostasis Model Assessment of Insulin Resistance, DM, and obesity. Incorporating liver fibrosis assessment using FibroScan may aid in the early identification of patients with MASLD who are at high risk for renal disease. |
| Publish Date |
2026-06-15 08:38 |
| Citation |
Azoz NM, Shehata MA, Abbas WA, Gadelkareem RA, Abdel Aziz EM. Is the metabolic dysfunction-associated steatotic liver disease a predictor of chronic kidney disease? World J Nephrol 2026; 15(2): 118877
|
| URL |
https://www.wjgnet.com/2220-6124/full/v15/i2/118877.htm |
| DOI |
https://doi.org/10.5527/wjn.v15.i2.118877 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
